News & updates.
Company announcements, scientific commentary and platform developments from the Fidēs team — alongside perspectives on early-phase imaging from across our network.
Why We Built Aperis
The thinking behind Aperis — built for how scientists actually interrogate imaging mid-study.
Showing 7 articles
No items found
Functional cardiac motion as an imaging endpoint in early cardiovascular development.
Read more
The Fidēs team will be at ECCO 2025 in Stockholm — book a meeting to talk early-phase GI imaging.
Read more
The decision problem at the heart of IBD trials, and how imaging can de-risk it earlier.
Read more
Rethinking response assessment in oncology with additive, mechanistically relevant imaging endpoints.
Read more
How Aperis gives sponsors continuous visibility of imaging data throughout a Phase I study.
Read more
Why motion and motility are powerful, under-used imaging endpoints in early-phase trials.
Read more
Fidēs Imaging opens its doors as a science-first imaging Core Lab focused on early-phase clinical development.
Read moreMore from the Fidēs resource library.
Case studies
Real programs, real imaging challenges and the scientific decisions behind them — across therapy areas and modalities.
View Case studiesPublications
Peer-reviewed science and contributed research from the Fidēs and Motilent scientific network.
View PublicationsEvents
Conferences, symposia and meetings where the Fidēs team will be present across the year.
View Events